MKC1106-PP

· MannKind Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MKC1106-PP, covering 2010-08-03 to 2010-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. [Phase 1]

See pricing